182 related articles for article (PubMed ID: 35872580)
21. The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
He Y; Gao Y; Ping L; He H; Huang C; Bai B; Wang X; Li Z; Cai Q; Huang Y; Pan X; Zeng W; Liu Y; Huang H
J Cancer Res Clin Oncol; 2023 May; 149(5):2017-2027. PubMed ID: 35809114
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous disease.
Jin Z; Wang Y; Wei N; Wang Z
Ann Hematol; 2020 Jul; 99(7):1575-1581. PubMed ID: 32500223
[TBL] [Abstract][Full Text] [Related]
23. Ruxolitinib treatment for SR-aGVHD in patients with EBV-HLH undergoing allo-HSCT.
Meng G; Wang J; Wang X; Wang Y; Wang Z
Ann Hematol; 2020 Feb; 99(2):343-349. PubMed ID: 31879790
[TBL] [Abstract][Full Text] [Related]
24. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Huang W; Gao Z; Pei R; Chen J; Jin Z; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):507-10. PubMed ID: 26134018
[TBL] [Abstract][Full Text] [Related]
25. A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis.
Zhang Q; Wei A; Ma HH; Zhang L; Lian HY; Wang D; Zhao YZ; Cui L; Li WJ; Yang Y; Wang TY; Li ZG; Zhang R
Haematologica; 2021 Jul; 106(7):1892-1901. PubMed ID: 32732367
[TBL] [Abstract][Full Text] [Related]
26. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S
J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902
[TBL] [Abstract][Full Text] [Related]
27. Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection.
Li Y; Li S; Lu N; Wang W; Wang D
Ann Hematol; 2024 May; 103(5):1541-1547. PubMed ID: 38467825
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and safety of modified hemophagocytic lymphohistiocytosis 04 regimen in Beijing Children's Hospital].
Cheng FF; Ma HH; Jiao Y; Wei A; Lian HY; Wang D; Yang Y; Zhao XX; Li ZG; Wang TY; Zhang R
Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):804-809. PubMed ID: 35922192
[No Abstract] [Full Text] [Related]
29. Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies.
Yildiz H; Bailly S; Van Den Neste E; Yombi JC
Ther Clin Risk Manag; 2021; 17():293-304. PubMed ID: 33888986
[TBL] [Abstract][Full Text] [Related]
30. Difficult Balance Between EBV Treatment and Posttransplant Immunosuppression: A Successful Transplant in a Child With Recurrent Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis.
Fałkowska A; Prądzyńska K; Drabko K
Transplant Proc; 2021; 53(6):2035-2039. PubMed ID: 33933286
[TBL] [Abstract][Full Text] [Related]
31. HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center.
Song Y; Wang J; Wang Y; Wang Z
Stem Cell Res Ther; 2020 Jul; 11(1):265. PubMed ID: 32611452
[TBL] [Abstract][Full Text] [Related]
32. Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients.
Yao S; He L; Zhang R; Liu M; Hua Z; Zou H; Wang Z; Wang Y
Ann Med; 2023 Dec; 55(1):89-100. PubMed ID: 36533966
[TBL] [Abstract][Full Text] [Related]
33. Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein-Barr virus infection.
Ma H; Zhang L; Wei A; Yang J; Wang D; Zhang Q; Zhao Y; Chen S; Lian H; Zhang L; Zhou C; Qin M; Li Z; Wang T; Zhang R
Orphanet J Rare Dis; 2021 Jun; 16(1):269. PubMed ID: 34112210
[TBL] [Abstract][Full Text] [Related]
34. Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center.
Huang Z; Jia Y; Zuo Y; Wu J; Lu A; Zhang L
Hematology; 2020 Dec; 25(1):389-399. PubMed ID: 33161882
[No Abstract] [Full Text] [Related]
35. Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis.
Chi Y; Liu R; Zhou ZX; Shi XD; Ding YC; Li JG
Pediatr Rheumatol Online J; 2021 Apr; 19(1):49. PubMed ID: 33794928
[TBL] [Abstract][Full Text] [Related]
36. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
[TBL] [Abstract][Full Text] [Related]
37. Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Song Y; Wang Y; Wang Z
Br J Haematol; 2019 Sep; 186(5):717-723. PubMed ID: 31115044
[TBL] [Abstract][Full Text] [Related]
38. Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children.
Pan H; Wang G; Guan E; Song L; Song A; Liu X; Yi Z; Sun LR
BMC Pediatr; 2020 Jun; 20(1):288. PubMed ID: 32517812
[TBL] [Abstract][Full Text] [Related]
39. Modified DEP regimen as induction therapy for lymphoma-associated hemophagocytic lymphohistiocytosis: a prospective, multicenter study.
Pi Y; Wang J; Zhou H; Ye X; Sun X; Liu L; Pan X; Wang Z
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3033-3041. PubMed ID: 35852619
[TBL] [Abstract][Full Text] [Related]
40. Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Li Z; Wang Y; Wang J; Zhang J; Wang Z
Leuk Lymphoma; 2018 Jan; 59(1):77-84. PubMed ID: 28573910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]